Original contributionImproved coronary magnetic resonance angiography using gadobenate dimeglumine in pediatric congenital heart disease-Science-Chemical Encyclopedia-lookchem

Original contributionImproved coronary magnetic resonance angiography using GADOBENATE DIMEGLUMINE (cas 12700-20-8) in pediatric congenital heart disease
Add time:08/28/2019 Source:sciencedirect.com

BackgroundCMRA in pediatrics remains challenging due to the smaller vessel size, high heart rates (HR), potential image degradation caused by limited patient cooperation and long acquisition times. High-relaxivity contrast agents have been shown to improve coronary imaging in adults, but limited data is available in children. We sought to investigate whether GADOBENATE DIMEGLUMINE (cas 12700-20-8) (Gd-BOPTA) together with self-navigated inversion-prepared coronary magnetic resonance angiography (CMRA) sequence design improves coronary image quality in pediatric patients.

We also recommend Trading Suppliers and Manufacturers of GADOBENATE DIMEGLUMINE (cas 12700-20-8). Pls Click Website Link as below: cas 12700-20-8 suppliers

Prev:Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of GADOBENATE DIMEGLUMINE (cas 12700-20-8) and 0.1 mmol/kg of gadoterate meglumine for cranial MRI
Next: Non-clinical assessment of safety and gadolinium deposition after cumulative administration of GADOBENATE DIMEGLUMINE (cas 12700-20-8) (MultiHance®) to neonatal and juvenile rats)

Click to view details

Encyclopedia